Patient
SITE007-0103
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2026-01-05
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-02 (study day 21); relationship: not assessed
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-07-31 (study day 19); relationship: NOT RELATED
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-31 (study day 19); relationship: not assessed
Grade 4 Decreased appetite — outcome: UNKNOWN; onset 2022-07-26 (study day 14); relationship: not assessed; serious criteria: life-threatening
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-26 (study day 14); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.